<DOC>
	<DOCNO>NCT01905189</DOCNO>
	<brief_summary>Pulmonary arterial hypertension disease characterise pathological change pulmonary artery lead progressive increase pulmonary vascular resistance pulmonary artery pressure . Right ventricular failure main cause death patient pulmonary arterial hypertension , ability right ventricle adapt progressive increase pulmonary vascular resistance associate change pulmonary vasculature pulmonary arterial hypertension main determinant patient 's functional capacity survival . Right ventricular dyssynchrony present substantial proportion patient pulmonary arterial hypertension dyssynchrony adversely affect right ventricular function .</brief_summary>
	<brief_title>Resynchronisation Therapy Right Ventricle Pulmonary Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>Pulmonary hypertension type I , III , IV , V Dana Point classification NYHA classification equal superior stage II During right catetherization : cardiac index inferior equal 2.5 L/mn/m2 atrial pressure superior equal 10 mmHg OR cardiac index equal inferior 2.2 L/mn/m2 Optimal therapy consider refer specialist practioner patient Minor incapacitate adult Pregnancy Unability give free inform consent Pulmonary hypertension type II Dana Point classification Eisenmenger syndrome Patent foramen ovale Left bundlebrach block Pulmonary hypertension exacerbation Medical clinical situation consider inappropriate investigator Patient eligible heartlung transplant Patient eligible pulmonary endarterectomy Patient poor echogenicity Filter inferior vena cava</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>pulmonary arterial hypertension</keyword>
	<keyword>cardiac resynchronization therapy</keyword>
</DOC>